KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $984,500 | +15.0% | 93,053 | +32.9% | 0.00% | – |
| Q1 2023 | $855,990 | +511.0% | 69,991 | +520.0% | 0.00% | – |
| Q4 2022 | $140,096 | -59.9% | 11,289 | -55.8% | 0.00% | – |
| Q3 2022 | $349,000 | +3.9% | 25,519 | +39.2% | 0.00% | – |
| Q2 2022 | $336,000 | +103.6% | 18,333 | +78.4% | 0.00% | – |
| Q1 2022 | $165,000 | -70.4% | 10,276 | -74.2% | 0.00% | – |
| Q4 2021 | $558,000 | +142.6% | 39,843 | +223.9% | 0.00% | – |
| Q3 2021 | $230,000 | -45.0% | 12,300 | -38.6% | 0.00% | – |
| Q2 2021 | $418,000 | -33.3% | 20,045 | -9.6% | 0.00% | – |
| Q1 2021 | $627,000 | -79.8% | 22,181 | -76.7% | 0.00% | -100.0% |
| Q4 2020 | $3,107,000 | +9.6% | 95,121 | +2.8% | 0.00% | +100.0% |
| Q3 2020 | $2,836,000 | +544.5% | 92,535 | +189.2% | 0.00% | 0.0% |
| Q4 2019 | $440,000 | +64.2% | 31,996 | +134.8% | 0.00% | – |
| Q2 2019 | $268,000 | – | 13,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |